Kenneth Melville, BSc’26, MDCM’26, MSc’31 (1902–1975) was an extraordinary man. Born in Jamaica, he was McGill’s first Black medical student and graduated at the top of his class in 1926. In 1953, he became the first – and only – Black Chair of McGill’s Department of Pharmacology & Therapeutics, becoming the first person from a developing country to hold a Chair at McGill. Dr. Melville was internationally respected and had a prolific scientific career. He served as a mentor for students from developing regions and was a leader in Montreal’s Caribbean community.
In the spirit of Dr. Melville’s legacy, the Department of Pharmacology & Therapeutics wishes to establish an Undergraduate Research Bursary that will provide funding for a paid summer research internship to an undergraduate student from an underrepresented equity group. The supervising professor and the Faculty of Medicine’s Social Accountability and Community Engagement Office will provide a formal mentorship program for the student.
This research experience provided by the bursary, combined with the mentorship opportunity, will increase the students' competitiveness for careers in science.
ATTENTION US-BASED DONORS
If you are based in the United States and are not an alumnus of McGill, you can still make a tax-deductible gift to the University through Friends of McGill University Inc. The organization’s IRS tax exempt ID is 23-7054819.
You can write a cheque to made out to “Friends of McGill University Inc”, and note “Pharmacology - Melville Bursary – 06965” on the cheque, and mail it to:
Friends of McGill University Inc.
P.O. Box 28137
New York, NY 10087-8137
- Chair of Department of Pharmacology & Therapeutics
- Assistant Professor and Chair of Melville Legacy Committee
- Member of Department of Pharmacology & Therapeutics Fundraising Committee
- Research Officer and Member of Melville Legacy Committee
- Undergraduate Student
- U3 Representative, PILS Council Pharmacology & Therapeutics
- Dr. Christopher Wright
- Grandson of Dr. Kenneth Melville
- Senior Vice President of Global Development and Chief Development Officer Ironwood Pharmaceuticals